Skip to main content

Written question asked by Ben Obese-Jecty (Conservative) on Thursday, 4 September 2025, in the House of Commons. It was due for an answer on Monday, 8 September 2025. It was answered by Kanishka Narayan (Labour) on Thursday, 18 September 2025 on behalf of the Department for Science, Innovation and Technology.


Animal Experiments

Question

To ask the Secretary of State for Science, Innovation and Technology, with reference to the UK’s Modern Industrial Strategy, CP 1337, published on 23 June 2025, what proportion of funding for Our Future Health will be allocated to (a) developing non-animal methods of testing and (b) phasing out animal testing.

Answer

Genomics England, Our Future Health and UK Biobank contribute important human data to the UK’s diverse research portfolio that supports alternative method development, including organ-on-a-chip, cell-based assays, functional genomics and computer modelling. The Health Data Research Service will also contribute in future, However, this research is not categorised by application, so calculating funding for alternative methods specifically is not possible. UKRI also invests £10 million annually in the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), with future investment under review.

The Government will publish a strategy to support alternative methods later this year.


Secondary information

Type
Written question
Reference
75339
Session
2024-26
Related items
The UK’s Modern Industrial Strategy
Monday, 23 June 2025
Command papers
House of Commons
House of Lords
Grouped for answer
Yes
Subjects
Animal experiments Finance Our Future Health
Contains statistics
Yes
Link
View this Written question on www.parliament.uk